Authors: Committe on the Framework for Evaluating the Safety of the Dietary Supplements, National Research Council
ISBN-13: 9780309091107, ISBN-10: 0309091101
Format: Hardcover
Publisher: National Academies Press
Date Published: December 2004
Edition: New Edition
Consumers may not be aware that under the Dietary Health and Education Act of 1994, manufactures of dietary supplements are not required to provide safety data. So rather than focusing on the efficacy of increasingly popular supplements, this committee was charged with developing a framework for the Food and Drug Administration's evaluation of their safety based on existing data. The project's legal context and evidence-based approach are overviewed. Appendices provide further details on other frameworks; the scope of the current project; the plant families reviewed; and offer examples of prototype monograph summaries, and summary tables of clinical case reports and animal studies. Annotation ©2004 Book News, Inc., Portland, OR
1 | Introduction and background | 19 |
2 | Approaches used by others and existing safety frameworks | 43 |
3 | The framework | 85 |
4 | Categories of scientific evidence - human information and data | 126 |
5 | Categories of scientific evidence - animal data | 156 |
6 | Categories of scientific evidence - information about related substances | 175 |
7 | Categories of scientific evidence - in vitro data | 217 |
8 | Interactions | 235 |
9 | Vulnerable groups and prevalence of use | 247 |
10 | Scientific principles for integrating and evaluating the available data | 253 |
11 | Applying the framework : case studies using the prototype safety monographs | 269 |
12 | Factors influencing use of the safety framework | 292 |
13 | Findings and recommendations | 297 |
App. A | Existing frameworks or systems for evaluating the safety of other substances | 307 |
App. B | Scope of work and comments to initial July 2002 framework | 316 |
App. C | Plant family information | 322 |
App. D | Chaparral : prototype monograph summary | 356 |
App. E | Glucosamine : prototype monograph summary | 363 |
App. F | Melatonin : prototype monograph summary | 367 |
App. G | Chromium picolinate : prototype monograph summary | 372 |
App. H | Saw palmetto : prototype monograph summary | 376 |
App. I | Shark cartilage : prototype monograph summary | 380 |
App. J | Prototype focused monograph : review of liver-related risks for chaparral | 385 |
App. K | Prototype focused monograph : review of antiandrogenic risks of saw palmetto ingestion by women | 450 |
App. L | Acknowledgments | 478 |
App. M | Biographical sketches of committee members | 481 |